Autolus raises 2026 AUCATZYL revenue guidance to $140 million to $150 million
Autolus raised its full-year 2026 AUCATZYL net product revenue guidance to $140 million to $150 million, up from $120 million to $135 million, and reported preliminary Q2 2026 AUCATZYL net product revenue of approximately $45 million. The company also entered a credit facility of up to $250 million with Perceptive Advisors, with $75 million funded at close, and expects its cash to fund operations into the second quarter of 2028.
Key points
- Full-year 2026 AUCATZYL net product revenue guidance raised to $140 million to $150 million, from $120 million to $135 million
- Preliminary Q2 2026 AUCATZYL net product revenue of approximately $45 million, up approximately 70% from Q1 2026 and more than 100% from Q2 2025
- Gross margin of approximately 35% year-to-date in 2026, compared with approximately negative 20% in the second half of 2025
- Five-year, interest-only credit facility with Perceptive of up to $250 million; $75 million issued July 30, 2026, at SOFR (3.50% floor) plus 7.25%, with a warrant for up to 3.5 million ADSs at $1.9314 per ADS
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 03, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.